The effects of the antecedent use of inhaled steroid on the clinical course of COVID-19: A retrospective study of asthmatic patients
Background: There is conflicting evidence regarding the effect of asthma and its different therapeutic options on COVID-19 severity and the clinical outcomes. Aim: This study aimed to investigate the relationship between using inhaled corticosteroids (ICS) by asthmatic patients and the severity of C...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Journal of Infection and Public Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1876034121004044 |
_version_ | 1798026682690437120 |
---|---|
author | Yousif S. Alakeel Ebtihal F. Alharbi Haifa A. Alhaidal Aisha M. Jumaa Latifah K. Albaiahy Noura S. Alsagami Shatha A. Alshahrani |
author_facet | Yousif S. Alakeel Ebtihal F. Alharbi Haifa A. Alhaidal Aisha M. Jumaa Latifah K. Albaiahy Noura S. Alsagami Shatha A. Alshahrani |
author_sort | Yousif S. Alakeel |
collection | DOAJ |
description | Background: There is conflicting evidence regarding the effect of asthma and its different therapeutic options on COVID-19 severity and the clinical outcomes. Aim: This study aimed to investigate the relationship between using inhaled corticosteroids (ICS) by asthmatic patients and the severity of COVID-19. Materials and methods: This retrospective observational study was conducted from March 15 to October 23, 2020 and included data of all COVID-19 asthmatic patients (n = 287) at King Abdulaziz Medical City. Twelve patients were excluded due to poor medication history documentation or using ICS for non-asthma indication. Ordinal logistic regression was used to determine the clinical variables that affect COVID-19 severity. The clinical outcomes of ICS and non-ICS users were compared. Results: Of the sample (n = 275), 198 (72%) were using ICS therapy. No significant difference was found between ICS and non-ICS users in disease severity (P = 0.12), mortality (P = 0.45), ICU admission (P = 0.78), and the occurrence of complications. However, the number of days on ventilation were significantly increased in ICS users (P = 0.006). Being prescribed the ICS/LABA combination (adj OR: 0.72 [0.15,1.2]; P = 0.021), being hypertensive (adj OR: 0.98 [0.28,1.6]; P = 0.006), having cancer (adj OR: 1.49 [0.12, 2.8]; P = 0.033), or having diabetes (adj OR: 0.75 [0.09, 1.4]; P = 0.024) could not increase the risk for more severe disease. Conclusion: Overall, ICS therapy did not alter the COVID-19 severity or mortality in asthmatic patients. The continued use of ICS during the pandemic should be encouraged to prevent asthma exacerbations. |
first_indexed | 2024-04-11T18:39:22Z |
format | Article |
id | doaj.art-149288528cb04519be96bf4f87095b1f |
institution | Directory Open Access Journal |
issn | 1876-0341 |
language | English |
last_indexed | 2024-04-11T18:39:22Z |
publishDate | 2022-01-01 |
publisher | Elsevier |
record_format | Article |
series | Journal of Infection and Public Health |
spelling | doaj.art-149288528cb04519be96bf4f87095b1f2022-12-22T04:09:03ZengElsevierJournal of Infection and Public Health1876-03412022-01-011515664The effects of the antecedent use of inhaled steroid on the clinical course of COVID-19: A retrospective study of asthmatic patientsYousif S. Alakeel0Ebtihal F. Alharbi1Haifa A. Alhaidal2Aisha M. Jumaa3Latifah K. Albaiahy4Noura S. Alsagami5Shatha A. Alshahrani6College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia; Pharmaceutical Care Department, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia; Corresponding author at: College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia; College of Applied Medical Sciences, Respiratory therapy Department, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi ArabiaCollege of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Riyadh, Saudi ArabiaKing Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia; Respiratory Services, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi ArabiaCollege of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Riyadh, Saudi ArabiaKing Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia; College of Applied Medical Sciences, Respiratory therapy Department, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi ArabiaKing Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia; College of Applied Medical Sciences, Respiratory therapy Department, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi ArabiaBackground: There is conflicting evidence regarding the effect of asthma and its different therapeutic options on COVID-19 severity and the clinical outcomes. Aim: This study aimed to investigate the relationship between using inhaled corticosteroids (ICS) by asthmatic patients and the severity of COVID-19. Materials and methods: This retrospective observational study was conducted from March 15 to October 23, 2020 and included data of all COVID-19 asthmatic patients (n = 287) at King Abdulaziz Medical City. Twelve patients were excluded due to poor medication history documentation or using ICS for non-asthma indication. Ordinal logistic regression was used to determine the clinical variables that affect COVID-19 severity. The clinical outcomes of ICS and non-ICS users were compared. Results: Of the sample (n = 275), 198 (72%) were using ICS therapy. No significant difference was found between ICS and non-ICS users in disease severity (P = 0.12), mortality (P = 0.45), ICU admission (P = 0.78), and the occurrence of complications. However, the number of days on ventilation were significantly increased in ICS users (P = 0.006). Being prescribed the ICS/LABA combination (adj OR: 0.72 [0.15,1.2]; P = 0.021), being hypertensive (adj OR: 0.98 [0.28,1.6]; P = 0.006), having cancer (adj OR: 1.49 [0.12, 2.8]; P = 0.033), or having diabetes (adj OR: 0.75 [0.09, 1.4]; P = 0.024) could not increase the risk for more severe disease. Conclusion: Overall, ICS therapy did not alter the COVID-19 severity or mortality in asthmatic patients. The continued use of ICS during the pandemic should be encouraged to prevent asthma exacerbations.http://www.sciencedirect.com/science/article/pii/S1876034121004044COVID-19AsthmaInhaled corticosteroidsViral infection |
spellingShingle | Yousif S. Alakeel Ebtihal F. Alharbi Haifa A. Alhaidal Aisha M. Jumaa Latifah K. Albaiahy Noura S. Alsagami Shatha A. Alshahrani The effects of the antecedent use of inhaled steroid on the clinical course of COVID-19: A retrospective study of asthmatic patients Journal of Infection and Public Health COVID-19 Asthma Inhaled corticosteroids Viral infection |
title | The effects of the antecedent use of inhaled steroid on the clinical course of COVID-19: A retrospective study of asthmatic patients |
title_full | The effects of the antecedent use of inhaled steroid on the clinical course of COVID-19: A retrospective study of asthmatic patients |
title_fullStr | The effects of the antecedent use of inhaled steroid on the clinical course of COVID-19: A retrospective study of asthmatic patients |
title_full_unstemmed | The effects of the antecedent use of inhaled steroid on the clinical course of COVID-19: A retrospective study of asthmatic patients |
title_short | The effects of the antecedent use of inhaled steroid on the clinical course of COVID-19: A retrospective study of asthmatic patients |
title_sort | effects of the antecedent use of inhaled steroid on the clinical course of covid 19 a retrospective study of asthmatic patients |
topic | COVID-19 Asthma Inhaled corticosteroids Viral infection |
url | http://www.sciencedirect.com/science/article/pii/S1876034121004044 |
work_keys_str_mv | AT yousifsalakeel theeffectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients AT ebtihalfalharbi theeffectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients AT haifaaalhaidal theeffectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients AT aishamjumaa theeffectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients AT latifahkalbaiahy theeffectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients AT nourasalsagami theeffectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients AT shathaaalshahrani theeffectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients AT yousifsalakeel effectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients AT ebtihalfalharbi effectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients AT haifaaalhaidal effectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients AT aishamjumaa effectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients AT latifahkalbaiahy effectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients AT nourasalsagami effectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients AT shathaaalshahrani effectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients |